<?xml version="1.0" ?>
<document id="d65ef4b00759d797d28454625b4de2814675bb56">
  <chunk id="d65ef4b00759d797d28454625b4de2814675bb56.c0" text="Interferon-induced HERC5 is evolving under positive selection and inhibits HIV-1 particle production by a novel mechanism targeting Rev/RRE-dependent RNA nuclear export Interferon-induced HERC5 is evolving under positive selection and inhibits HIV-1 particle production by a novel mechanism targeting Rev/RRE-dependent RNA nuclear export">
    <entity charOffset="150-153" id="d65ef4b00759d797d28454625b4de2814675bb56.c0.e0" ontology_id="CHEBI_33697" text="RNA" type="chemical"/>
    <entity charOffset="319-322" id="d65ef4b00759d797d28454625b4de2814675bb56.c0.e1" ontology_id="CHEBI_33697" text="RNA" type="chemical"/>
  </chunk>
  <chunk id="d65ef4b00759d797d28454625b4de2814675bb56.c1" text="Background: Type I interferon (IFN) inhibits virus replication by activating multiple antiviral mechanisms and pathways. It has long been recognized that type I IFNs can potently block HIV-1 replication in vitro; as such, HIV-1 has been used as a system to identify and characterize IFN-induced antiviral proteins responsible for this block. IFN-induced HERC5 contains an amino-terminal Regulator of Chromosome Condensation 1 (RCC1)-like domain and a carboxyl-terminal Homologous to the E6-AP Carboxyl Terminus (HECT) domain. HERC5 is the main cellular E3 ligase that conjugates the IFN-induced protein ISG15 to proteins. This E3 ligase activity was previously shown to inhibit the replication of evolutionarily diverse viruses, including HIV-1. The contribution of the RCC1-like domain to the antiviral activity of HERC5 was previously unknown.">
    <entity charOffset="19-29" id="d65ef4b00759d797d28454625b4de2814675bb56.c1.e0" ontology_id="CHEBI_52999" text="interferon" type="chemical"/>
    <entity charOffset="86-95" id="d65ef4b00759d797d28454625b4de2814675bb56.c1.e1" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="295-304" id="d65ef4b00759d797d28454625b4de2814675bb56.c1.e2" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="305-313" id="d65ef4b00759d797d28454625b4de2814675bb56.c1.e3" ontology_id="CHEBI_36080" text="proteins" type="chemical"/>
    <entity charOffset="595-602" id="d65ef4b00759d797d28454625b4de2814675bb56.c1.e4" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="612-620" id="d65ef4b00759d797d28454625b4de2814675bb56.c1.e5" ontology_id="CHEBI_36080" text="proteins" type="chemical"/>
    <entity charOffset="794-803" id="d65ef4b00759d797d28454625b4de2814675bb56.c1.e6" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
  </chunk>
  <chunk id="d65ef4b00759d797d28454625b4de2814675bb56.c2" text="Results: In this study, we showed that HERC5 inhibits HIV-1 particle production by a second distinct mechanism that targets the nuclear export of Rev/RRE-dependent RNA. Unexpectedly, the E3 ligase activity of HERC5 was not required for this inhibition. Instead, this activity required the amino-terminal RCC1-like domain of HERC5. Inhibition correlated with a reduction in intracellular RanGTP protein levels and/or the ability of RanGTP to interact with RanBP1. Inhibition also correlated with altered subcellular localization of HIV-1 Rev. In addition, we demonstrated that positive evolutionary selection is operating on HERC5. We identified a region in the RCC1-like domain that exhibits an exceptionally high probability of having evolved under positive selection and showed that this region is required for HERC5-mediated inhibition of nuclear export. Conclusions: We have identified a second distinct mechanism by which HERC5 inhibits HIV-1 replication and demonstrate that HERC5 is evolving under strong positive selection. Together, our findings contribute to a growing body of evidence suggesting that HERC5 is a novel host restriction factor.">
    <entity charOffset="394-401" id="d65ef4b00759d797d28454625b4de2814675bb56.c2.e0" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
  </chunk>
</document>
